VolitionRX (VNRX)
NYSE MKT:VNRX
US Market
Holding VNRX?
Track your performance easily

VolitionRX (VNRX) Financial Statements

435 Followers

VolitionRX Financial Overview

VolitionRX's market cap is currently ―. The company's EPS TTM is $-0.457; its P/E ratio is -1.44; VolitionRX is scheduled to report earnings on August 12, 2024, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 171.53K$ 165.20K$ 216.31K$ 149.81K$ 119.72K
Gross Profit$ 171.53K$ 165.21K$ 216.31K$ 149.81K$ 119.72K
EBIT$ -8.57M$ -8.40M$ -9.49M$ -8.88M$ -7.35M
EBITDA$ -8.24M$ -8.04M$ -9.14M$ -9.15M$ -8.06M
Net Income Common Stockholders$ -8.37M$ -8.37M$ -9.55M$ -8.78M$ 8.04M
Balance Sheet-
Cash Cash Equivalents And Short Term Investments$ 11.77M$ 10.81M$ 19.74M$ 10.01M$ 10.87M
Total Assets$ 19.43M$ 18.04M$ 27.56M$ 18.04M$ 18.30M
Total Debt$ 5.55M$ 4.30M$ 4.68M$ 4.77M$ 4.97M
Net Debt$ -6.22M$ -6.50M$ -15.07M$ -5.24M$ -5.89M
Total Liabilities$ 36.05M$ 20.89M$ 22.44M$ 21.02M$ 21.42M
Stockholders Equity$ -15.61M$ -2.04M$ 5.84M$ -2.34M$ -3.13M
Cash Flow-
Free Cash Flow$ -8.37M$ -8.69M$ -7.65M$ -8.95M$ -5.76M
Operating Cash Flow$ -8.34M$ -8.42M$ -7.35M$ -8.74M$ -5.18M
Investing Cash Flow$ -78.81K$ -273.04K$ -301.39K$ -200.59K$ -578.75K
Financing Cash Flow$ -209.40K$ -274.76K$ 17.34M$ 8.15M$ 305.42K
Currency in USD

VolitionRX Earnings and Revenue History

VolitionRX Debt to Assets

VolitionRX Cash Flow

VolitionRX Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis